LSDIF (Lucy Scientific Discovery) EV-to-EBIT: 0.00 (As of Jul. 11, 2026)


What is Lucy Scientific Discovery EV-to-EBIT?

Lucy Scientific Discovery LSDIF EV-to-EBIT is 0.00 as of Jul. 11, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Lucy Scientific Discovery's Enterprise Value is $0.00 Mil. Lucy Scientific Discovery's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.53 Mil. Therefore, Lucy Scientific Discovery's EV-to-EBIT for today is 0.00.

The historical rank and industry rank for Lucy Scientific Discovery's EV-to-EBIT or its related term are showing as below:

LSDIF's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.81
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Lucy Scientific Discovery's Enterprise Value for the quarter that ended in Dec. 2023 was $6.52 Mil. Lucy Scientific Discovery's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-8.53 Mil. Lucy Scientific Discovery's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -130.76%.

Lucy Scientific Discovery  (OTCPK:LSDIF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Lucy Scientific Discovery's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-8.527/6.5212825
=-130.76 %

Lucy Scientific Discovery's Enterprise Value for the quarter that ended in Dec. 2023 was $6.52 Mil.
Lucy Scientific Discovery's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery EV-to-EBIT Related Terms

Lucy Scientific Discovery EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery EV-to-EBIT Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
EV-to-EBIT
0.00 0.00 -2.88

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 -2.98 -2.88 -1.60 -0.76

LSDIF vs INQD, ZTS, VTRS: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lucy Scientific Discovery EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lucy Scientific Discovery's EV-to-EBIT falls into.


Lucy Scientific Discovery EV-to-EBIT Calculation

Lucy Scientific Discovery's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-8.527
=0.00

Lucy Scientific Discovery's current Enterprise Value is $0.00 Mil.
Lucy Scientific Discovery's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of 0.00 mean?
Lucy Scientific Discovery (LSDIF) has a EV-to-EBIT of 0.00 as of Jul. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's EV-to-EBIT too high?
Lucy Scientific Discovery's current EV-to-EBIT is 0.00.
How does Lucy Scientific Discovery's EV-to-EBIT compare to INQD and ZTS?
Lucy Scientific Discovery's EV-to-EBIT of 0.00 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.81, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lucy Scientific Discovery and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lucy Scientific Discovery's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current EV-to-EBIT is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.